Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 42%
Hold 42%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein Inc. demonstrated robust revenue growth across its key segments, with medical products revenue increasing by 4.7% as reported and 3.0% on a local internal basis, while dental business revenue rose by 2.7%. The global technology segment also experienced significant expansion, generating $173 million in revenue with a growth rate of 9.7% as reported and 9.0% on a local internal basis. Additionally, the forecast for adjusted EBITDA in 2025 suggests a mid-single-digit growth, reflecting the company's strong operational performance and positive outlook for future earnings.

Bears say

Henry Schein Inc. experienced a significant decline in profitability, with a gross margin of 31.4% that fell 110 basis points year-over-year and missed expectations by 60 basis points. The company's US dental merchandise revenue decreased by 1.2%, attributed to pricing pressure, while international merchandise revenue showed only marginal growth of 1.9% but also suffered a local internal decline. Consequently, adjusted EBITDA projections for fiscal year 2025 have been reduced to $1.090 billion, indicating a potential slowdown in growth and highlighting the challenges faced in maintaining profitability amidst competitive pricing pressures.

Henry Schein (HSIC) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 42% recommend Buy, 42% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 12 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.